CoChat

Spectrum of Efficacy of Valproate in 78 Rapid-Cycling Bipolar Patients

CALABRESE, JOSEPH R., MARKOVITZ, PAUL J., KIMMEL, SUSAN E., WAGNER, SUSAN C. · 1992 · Journal of Clinical Psychopharmacology
Cited by 144

The DOI matches its Crossref record.

Abstract

The rapid-cycling variant of bipolar disorder constitutes about 15%-20% of all bipolar patients, and 72%-82% of these patients exhibit less than adequate response to lithium therapy. Valproate's spec- trum of efficacy was examined in 78 patients with rapid-cycling bipolar disorder in a prospective, open, 15.8-month trial. Thirty patients received valproate monotherapy and 48 received combination therapy. Treatment assignment was nonrandomized and based on prior treatment history. A marked acute response was seen in 54% of the patients with mania, 87% of those with mixed states, and 19% of those with depression. Marked prophylactic responses were seen in 72% of manic patients, 94% of mixed states patients, and 33% of depressed patients. In addition, moderate acute antimanic responses were observed in another 31% of the patients, prophylactic antimanic responses in 17%, acute antimixed state responses in 0%, prophylactic antimixed state responses in 0%, acute antidepressant responses in 25%, and prophylactic antidepressant responses in mixed states in 34%. Pattern analysis was conducted to examine the spectrum of efficacy of valproate in various cells (e.g., the cohort of patients who had an acute antimanic response to the drug). Pattern analysis showed that 40% of the patients with a marked prophylactic antimanic response had a marked antidepressant response to valproate. However, among the patients with a marked antidepressant response to valproate, 91% had a marked antimanic response. The most common side effects of valproate in our study, as in earlier studies, were gastrointestinal problems (nausea, stomach cramps, diarrhea), tremors, lethargy, and hair thinning. Life charting techniques disclosed a bimodal distribution of episode frequencies, with the first mean approximating 10 episodes per year and the second estimated at 30 per year or too numerous to count. Consistent with previous observations, our data suggest that valproate has marked antimanic efficacy, minimal to moderate antidepressant properties, and marked antimixed state efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199202001-00008

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 144

Metadata

Authors
CALABRESE, J. R., MARKOVITZ, P. J., KIMMEL, S. E., & WAGNER, S. C.
Venue
Journal of Clinical Psychopharmacology
Published
1992-02
Volume
12
Issue
Supplement
Pages
53S-56S
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2066627514
Cited by
144
References
0
FWCI
4.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spectrum of Efficacy of Valproate in 78 Rapid-Cycling Bipolar Patients. https://app.cochat.ai/papers/10.1097/00004714-199202001-00008
The paper
CALABRESE, J. R., MARKOVITZ, P. J., KIMMEL, S. E., & WAGNER, S. C. (1992). Spectrum of Efficacy of Valproate in 78 Rapid-Cycling Bipolar Patients. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199202001-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.